After the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...

Anvita Kamath, diagnosed with breast cancer at 28, faced a grueling treatment after discovering the disease had spread to her lymph nodes. ...

Novartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Zydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

A groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...

Biocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...

Israeli Prime Minister Benjamin Netanyahu announced successful treatment for early-stage prostate cancer. A routine checkup revealed a mali...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

Aarav Vats’ remarkable achievement of scoring 96.6% in the CBSE Class 10 examinations, despite battling Lymphoblastic Lymphoma for two year...

What is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...

US stocks rose as investors weighed Middle East tensions and hopes of a potential resolution in the Iran conflict. Gains in tech stocks lif...

Swiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...

In a groundbreaking discovery, scientists at the City of Hope, a leading cancer research institute in the US, have developed a game-changin...

The molecule has shown potency in cells to completely reduce tumour in 50 days.